U.S. Chemicals Stock News

New Horizon Aircraft (NasdaqCM:HOVR) is making headlines after announcing a partnership and purchase agreement with Pratt & Whitney Canada for the PT6A engine, which is set to power its Cavorite X7 hybrid eVTOL aircraft. The deal marks meaningful progress on prototype development and signals the company’s commitment to delivering practical innovation in advanced air mobility. See our latest analysis for New Horizon Aircraft. Shares of New Horizon Aircraft have soared in 2025, supercharged by...

Earlier in October 2025, Protalix BioTherapeutics and Chiesi Group received a negative opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) regarding Elfabrio’s proposed less-frequent dosing regimen for Fabry disease, as the data was considered insufficient to demonstrate similar efficacy to the currently approved schedule. This regulatory decision highlights ongoing challenges in achieving flexibility for rare disease treatments, with...

As of October 2025, the U.S. stock market has navigated a volatile week with major indices such as the Nasdaq and S&P 500 recording solid gains, despite ongoing concerns about banking sector health and geopolitical tensions. In this dynamic environment, high growth tech stocks in the U.S. remain a focal point for investors seeking opportunities that align with robust innovation trends and potential resilience amid economic fluctuations.

As the U.S. stock market concludes a volatile week with major indices posting gains, investors are navigating through concerns about banking sector health and trade tensions with China. In this environment, identifying stocks that are potentially undervalued can offer opportunities for those looking to capitalize on discrepancies between market prices and intrinsic values.

As the U.S. stock market navigates a volatile landscape marked by fluctuating indices and economic uncertainties, investors continue to seek opportunities in growth companies that demonstrate robust potential. In this context, high insider ownership often signals confidence in a company's future prospects, making such stocks particularly appealing amidst the current market dynamics.

As the U.S. markets close higher after a volatile week, investors are keenly observing opportunities that might arise amidst fluctuating conditions and economic uncertainties. Penny stocks, often seen as relics of speculative trading, still hold potential when underpinned by solid financials and growth prospects. In this article, we explore three penny stocks that exemplify strong balance sheets and promising fundamentals, offering investors a chance to uncover hidden value in companies with...

The Morning Bull - US Market Morning Update Monday, Oct, 20 2025 US market futures are pointing higher this morning, lifted by optimism around easing trade tensions and a dip in long-term interest rates. Investors are weighing improved fiscal data against the backdrop of a prolonged government shutdown. There is continued caution as uncertainty shapes expectations for growth and puts pressure on consumer-focused names to deliver steady performance. Uncertainty favors prepared investors. Act...

Insiders who purchased Fossil Group, Inc. ( NASDAQ:FOSL ) shares in the past 12 months are unlikely to be deeply...

Dominari Holdings Inc. ( NASDAQ:DOMH ) shareholders might be concerned after seeing the share price drop 15% in the...

Casella Waste Systems, Inc. ( NASDAQ:CWST ), might not be a large cap stock, but it saw significant share price...

Achieve Life Sciences recently announced that the U.S. Food and Drug Administration awarded the company a rare Commissioner's National Priority Voucher, expediting the review of cytisinicline for nicotine dependence in e-cigarette or vaping cessation. This first-of-its-kind designation, paired with Breakthrough Therapy status and promising clinical trial results, puts cytisinicline at the forefront of developing a dedicated treatment for vaping cessation, an area with significant unmet...

Rekor Systems announced in October 2025 that the California and Texas Departments of Transportation have begun using Rekor Discover®, following its largest statewide contract to date with the Georgia DOT, which could reach over US$100 million in value. This sequence of wins, including a recent technology award and initial order in South Carolina, highlights Rekor's growing traction with state transportation agencies and the increasing relevance of its AI-powered data solutions for modern...

First Industrial Realty Trust (FR) posted a net profit margin of 33.2%, a step down from last year's 47% margin. The five-year average annual earnings growth sits at 3.7%. Looking ahead, the company expects earnings to grow at 5.05% per year and revenue at 7.2% per year, both trailing the broader US market's expected growth. Investors will be closely watching how First Industrial balances profitability and growth in the face of ongoing margin pressures and a financial position flagged as a...

Thinking about what to do with Newsmax stock? You’re not alone; this is the question on the minds of many investors right now. Newsmax has been in the spotlight due to some sharp price swings, and whether you’re already holding shares or considering jumping in, it’s important to look past the headlines and dig into what’s really happening with this stock. In the past month, Newsmax shares have dropped 13.7%, adding to a tough year-to-date slide of 86.7%. Over the last week, things have been...

NETGEAR (NTGR) shares have seen some interesting movement recently, with the stock gaining over 13% in the past month. Investors may be weighing the company’s steady annual revenue growth as well as ongoing changes in the tech sector. See our latest analysis for NETGEAR. While NETGEAR's 1-month share price return of 13.2% signals renewed momentum, the stock's 1-year total shareholder return stands at an impressive 50.7%. This suggests that although gains have recently accelerated, long-term...

Thinking about what to do next with BioLife Solutions stock? You are not alone. Over the past year, shares have quietly climbed 15.6%, and while that performance might catch your eye, it is the bigger context that makes this stock so interesting right now. Investors have watched it rebound 6.8% in just the last 30 days, adding to a 4.4% gain year-to-date. Yet, when looking further back, the five-year total return lags at -5.9%, painting a far more complex picture. So, what is driving this...

If you’re wondering what to do about Manhattan Associates stock at this crossroads, you’re in good company. The once high-flying supply chain software specialist has caught the attention of investors trying to make sense of recent swings. Despite an impressive 54.3% three-year return and a remarkable 101.9% gain over five years, the stock is now catching its breath. Over the past month, shares have slipped by 8.4%, pushing year-to-date performance down to -26.8%, with a full-year drop to...

Cryoport, Inc. recently unveiled new integrated condition monitoring solutions for its MVE Biological Solutions dewars, incorporating the SmartTag and CryoBeacon devices powered by Tec4Med, with data centralized in the FDA-compliant MVECloud platform for enhanced monitoring of cryogenic storage. This innovation offers life sciences companies real-time visibility and improved safety for temperature-sensitive commodities, reflecting an ongoing push toward advanced digital and compliance...

Quantum-Si recently introduced its V4 Sequencing Kit, designed to enhance protein analysis by expanding sequencing coverage and improving detection of specific amino acids. This technological advance stands out for its potential to significantly strengthen the company’s protein sequencing platform in the evolving life sciences sector. We'll look at how the V4 Sequencing Kit's improved capabilities shape Quantum-Si's investment narrative amid shifting market attention. Find companies with...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

AVITA Medical (RCEL) shares have drawn attention after Chairman Cary Vance was named Interim CEO, replacing Jim Corbett. This leadership shift comes as preliminary third-quarter revenue comes in below expectations and ongoing talks with lenders continue. See our latest analysis for AVITA Medical. Shares of AVITA Medical have struggled through 2025, with the 1-day share price return plunging 25.84% after the CEO transition and softer revenue update. Short-term momentum has clearly faded. With...

Key Insights Williams Companies' estimated fair value is US$68.22 based on 2 Stage Free Cash Flow to Equity With...

We'd be surprised if Byrna Technologies Inc. ( NASDAQ:BYRN ) shareholders haven't noticed that the Independent...